Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2000-7-11
pubmed:abstractText
Nef is a lentiviral protein involved in pathogenesis of AIDS, but its molecular mechanisms of action remain incompletely understood. Here we report a novel effect of Nef on lymphocyte signaling, which is mediated via a T cell receptor (TCR)-independent contribution of Nef to induction of nuclear factor of activated T cells (NFAT), a transcription factor that plays a central role in coordinating T cell activation. Expression of Nef did not significantly alter the basal level of NFAT activity in Jurkat cells nor the increased activity following T cell receptor stimulation by anti-CD3 or anti-CD3 + anti-CD28. We also mimicked NFAT induction by TCR triggering by simultaneous activation of the Ras and calcium signaling pathways with phorbol 12-myristate 13-acetate and ionomycin, respectively. Strikingly, whereas activation of either of these pathways individually did not induce NFAT activity in control cells, in Nef-expressing cells phorbol 12-myristate 13-acetate treatment alone resulted in a 100-fold increase in NFAT-directed gene expression. Experiments with different dominant negative mutant signaling proteins, inhibitory chemicals, and Lck-deficient Jurkat cells revealed that this effect was mediated via activation of calcineurin by Nef-induced changes in calcium metabolism, but was independent of TCR-associated signaling events. This ability of Nef to substitute for triggering of the calcium pathway in induction of NFAT could promote activation of human immunodeficiency virus (HIV)-infected T cells in response to stimuli mediated via TCR or other cell surface receptors under conditions when activation of Ras rather than calcium signaling would otherwise predominate.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, nef, http://linkedlifedata.com/resource/pubmed/chemical/NFATC Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell, http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/nef Gene Products, Human..., http://linkedlifedata.com/resource/pubmed/chemical/ras Proteins
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
275
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
16513-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10748182-Calcium Signaling, pubmed-meshheading:10748182-Cell Line, pubmed-meshheading:10748182-DNA-Binding Proteins, pubmed-meshheading:10748182-Enzyme Inhibitors, pubmed-meshheading:10748182-Gene Products, nef, pubmed-meshheading:10748182-HIV-1, pubmed-meshheading:10748182-Humans, pubmed-meshheading:10748182-MAP Kinase Signaling System, pubmed-meshheading:10748182-NFATC Transcription Factors, pubmed-meshheading:10748182-Nuclear Proteins, pubmed-meshheading:10748182-Protein Kinase Inhibitors, pubmed-meshheading:10748182-Protein Kinases, pubmed-meshheading:10748182-Receptors, Antigen, T-Cell, pubmed-meshheading:10748182-Tetradecanoylphorbol Acetate, pubmed-meshheading:10748182-Transcription Factors, pubmed-meshheading:10748182-nef Gene Products, Human Immunodeficiency Virus, pubmed-meshheading:10748182-ras Proteins
pubmed:year
2000
pubmed:articleTitle
Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway.
pubmed:affiliation
Institute of Medical Technology, University of Tampere, P. O. Box 607, FIN-33101 and the Department of Clinical Chemistry, Tampere University Hospital, P. O. Box 2000, FIN-33521, Tampere, Finland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't